How does electrospray ionisation produce peptide ions?
Electrospray ionisation works by applying a high voltage to a liquid sample as it passes through a narrow capillary, generating a fine spray of charged droplets. As solvent evaporates, the droplets shrink until charge density forces the emission of desolvated gas-phase ions. For peptides analysed in positive ion mode, protonation typically occurs at basic residues and the N-terminus, producing ions carrying multiple positive charges. The technique was established as a powerful tool for peptide and protein analysis from its early development, with foundational work demonstrating that intact large biomolecules could be ionised without fragmentation (PMID:2774189; PMID:2074829). A key practical consequence is that a single peptide does not appear at one mass-to-charge (m/z) value. Instead it generates a characteristic envelope of peaks, each corresponding to a different charge state. Because mass spectrometers separate ions by m/z rather than by mass alone, multiple charging shifts large molecules into a lower, more readily measured m/z window. Solvent composition (commonly water/acetonitrile with a volatile acid modifier), capillary voltage, source temperature and flow rate all influence ionisation efficiency and the observed charge-state distribution. Recent work has applied machine learning to predict peptide ionisation efficiencies, reflecting how sequence and physicochemical properties govern signal response (PMID:39250640). For molecular weight determination, the analyst's goal is a clean, well-resolved charge-state series with adequate signal-to-noise, from which an accurate neutral mass can be reconstructed.
Why do peptides show multiple charge states and how is mass calculated?
Each peak in an ESI peptide spectrum corresponds to the molecule carrying a different number of protons. A peak observed at a given m/z relates to the neutral monoisotopic or average mass by the relationship m/z = (M + nH)/n, where M is the neutral mass, n is the number of charges, and H is the mass of a proton (approximately 1.0073 Da). Because adjacent peaks in the envelope differ by exactly one charge, two consecutive peaks provide enough information to solve for both n and M algebraically. In practice, software performs this calculation across the whole envelope to maximise confidence. The presence of several charge states is analytically advantageous: it provides multiple independent measurements of the same molecule, and agreement between them increases certainty in the assigned mass. Biological mass spectrometry primers describe this multiple-charging behaviour as a defining and useful feature of ESI for peptides and proteins (PMID:10970448). Early molecular weight determinations of recombinant proteins by ESI demonstrated that masses could be assigned with high precision by exploiting the multiply charged series (PMID:1804419). For small peptides, lower charge states (commonly singly or doubly protonated) dominate, while larger sequences produce broader envelopes. Analysts must also account for adducts such as sodium or potassium, which add characteristic mass shifts and can complicate interpretation if not recognised. Distinguishing genuine charge states from adducts and from co-eluting impurities is a core interpretive skill in molecular weight confirmation.
What is spectral deconvolution and why does it matter?
Deconvolution is the computational process of converting a multiply charged m/z spectrum into a single, zero-charge mass spectrum that reports the neutral molecular weight directly. Rather than interpreting a confusing series of peaks at different m/z values, the analyst obtains one peak (or isotope cluster) at the calculated mass, which is far easier to compare against a theoretical value. Algorithms such as maximum-entropy and charge-deconvolution methods evaluate the entire charge-state envelope simultaneously, assigning charge states and combining the information into a coherent mass estimate. The quality of deconvolution depends on input data: well-resolved, baseline-separated charge states with good signal-to-noise produce reliable results, whereas noisy or overlapping envelopes can generate artefactual peaks. For peptides, the choice between reporting monoisotopic mass (the mass calculated using the most abundant isotope of each element) and average mass (weighted across natural isotopic abundances) matters and must be stated explicitly. High-resolution instruments can resolve the isotopic envelope, enabling monoisotopic mass assignment and direct charge-state determination from isotope spacing. Lower-resolution instruments typically report average mass. Consistent documentation of which mass type is reported, the deconvolution software and parameters used, and the m/z range processed is essential for reproducible records. Complementary separation methods such as size-exclusion chromatography (PMID:12834979) can be coupled upstream to reduce sample complexity before ESI, improving deconvolution quality for mixtures.
What mass accuracy and resolution are expected for peptide identity?
Mass accuracy describes how closely a measured mass matches the theoretical value, usually expressed in parts per million (ppm) or in Daltons. Resolution describes the instrument's ability to separate two peaks of similar m/z and is critical for resolving isotopes and adjacent charge states. The achievable performance depends on the analyser: quadrupole and ion-trap instruments offer modest resolution suited to routine average-mass confirmation, while time-of-flight, Orbitrap and Fourier-transform analysers deliver high resolution and sub-ppm to low-ppm accuracy enabling monoisotopic assignment. For peptide identity confirmation, the experimental mass is compared against a theoretical mass calculated from the amino acid sequence, accounting for any expected modifications such as amidation, acetylation or disulfide formation. A disulfide bond, for example, reduces mass by approximately 2 Da per bond relative to the reduced form, and this difference is diagnostic. Acceptance criteria are typically defined as a maximum permitted deviation between observed and theoretical mass; the exact tolerance is set according to instrument capability and method validation. Calibration with reference standards immediately before analysis underpins accuracy, and recording the calibration status, instrument type, resolution setting and observed versus theoretical mass forms the analytical backbone of an identity record. ESI-MS has long been applied to confirm masses of low molecular weight species and modified compounds with high reliability (PMID:10892588), illustrating how broadly applicable accurate mass measurement is across analyte classes.
How does ESI-MS fit into a peptide quality control workflow?
Molecular weight confirmation by ESI-MS answers the identity question: is the molecule present the one expected from the stated sequence? It is therefore complementary to, not a replacement for, other analytical tests. Reversed-phase HPLC assesses chromatographic purity and resolves related substances; amino acid analysis quantifies composition; and orthogonal spectroscopic methods characterise structure. Mass spectrometry contributes a definitive identity dimension and can also flag certain impurities, truncations or oxidation products that shift mass in predictable ways. A typical research QC sequence applies a separation step, captures the mass spectrum, deconvolutes the charge-state envelope, and compares the resulting mass against the calculated theoretical value within a defined tolerance. Mass spectrometry has also been used to identify and characterise low molecular weight species in complex experimental systems, underscoring its versatility beyond simple identity checks (PMID:30909659). For documentation, a complete ESI-MS record should capture the sample identifier and batch, instrument and analyser type, ionisation mode, calibration details, the raw m/z charge states observed, the deconvoluted mass, whether the value is monoisotopic or average, the theoretical mass and sequence used, the deviation, and the analyst and date. These records feed into the certificate of analysis and the broader traceability system. Standardised, well-controlled ESI-MS methodology ensures that identity data are reproducible across batches and defensible under audit, supporting rigorous research-only quality practices without reference to any biological effect.
Frequently asked questions
Why does a single peptide show several peaks in an ESI spectrum?
Electrospray ionisation produces ions carrying different numbers of charges, so one peptide appears as a series of peaks at different mass-to-charge values. Each peak represents a distinct charge state. Software uses the spacing between adjacent peaks to calculate both the charge number and the underlying neutral molecular mass.
What is the difference between monoisotopic and average mass?
Monoisotopic mass is calculated using the single most abundant isotope of each element, while average mass is weighted across all natural isotopes. High-resolution instruments resolve isotopes and report monoisotopic mass; lower-resolution instruments typically report average mass. A record should always state which value is being reported.
How accurate is ESI-MS for peptide molecular weight?
Accuracy depends on the analyser. High-resolution instruments such as time-of-flight or Orbitrap can achieve low-ppm accuracy, enabling confident monoisotopic assignment. Routine quadrupole or ion-trap analysers deliver lower resolution suited to average-mass confirmation. Calibration with reference standards before analysis is essential to achieving stated accuracy.
What is spectral deconvolution?
Deconvolution is the computational conversion of a multiply charged m/z spectrum into a single zero-charge mass spectrum. It assigns charge states across the full envelope and reports the neutral molecular weight directly, making comparison against a theoretical mass straightforward. Result quality depends on well-resolved peaks with good signal-to-noise.
How does ESI-MS complement HPLC in peptide QC?
ESI-MS confirms identity by measuring molecular mass, whereas reversed-phase HPLC assesses chromatographic purity and resolves related substances. The two are orthogonal: mass spectrometry answers what the molecule is, while HPLC characterises how pure it is. Used together they provide a more complete analytical picture for documentation.
References
- PubMed PMID:2774189 — Peptide and protein analysis by electrospray ionization-mass spectrometry and capillary electrophoresis-mass spectrometry — 1989
- PubMed PMID:2074829 — Electrospray ionization mass spectrometry — 1990
- PubMed PMID:10970448 — Biological mass spectrometry: a primer — 2000
- PubMed PMID:1804419 — Molecular weight determination of recombinant interleukin 2 and interferon gamma by electrospray ionization mass spectroscopy — 1991
- PubMed PMID:39250640 — Predicting Peptide Ionization Efficiencies for Electrospray Ionization Mass Spectrometry Using Machine Learning — 2024
- PubMed PMID:10892588 — Electrospray ionization mass spectrometry of low-molecular-mass S-nitroso compounds and their thiols — 2000
- PubMed PMID:12834979 — High-performance size-exclusion chromatography of peptides — 2003
- PubMed PMID:30909659 — Contributions of Mass Spectrometry to the Identification of Low Molecular Weight Molecules Able to Reduce the Toxicity of Amyloid-β Peptide to Cell Cultures and Transgenic Mouse Models of Alzheimer's Disease — 2019
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
